113 related articles for article (PubMed ID: 10560401)
1. [Distribution of lymphocytes to tumor tissue and regional lymph nodes in patients with gastric cancer--the effects of oral administration of OK-432].
Yoshikawa T; Saito M; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Yanoma S; Ono Y
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1813-6. PubMed ID: 10560401
[TBL] [Abstract][Full Text] [Related]
2. [Effect of endoscopic local injection of OK-432 on regional lymph nodes in gastric cancer patients].
Ogawara T; Sakai K; Sekikawa T; Kouno K; Matsumoto Y
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1601-4. PubMed ID: 1530316
[TBL] [Abstract][Full Text] [Related]
3. The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients.
Gochi A; Orita K; Fuchimoto S; Tanaka N; Ogawa N
Br J Cancer; 2001 Feb; 84(4):443-51. PubMed ID: 11207036
[TBL] [Abstract][Full Text] [Related]
4. [Preoperative immunotherapy in patients with gastric cancer--with special reference to analysis with monoclonal antibodies of T-lymphocyte subsets and interleukin-2 oral administration of OK-432 (Picibanil)].
Izumi M
Nihon Geka Gakkai Zasshi; 1993 Jan; 94(1):27-32. PubMed ID: 8437550
[TBL] [Abstract][Full Text] [Related]
5. Orally administered streptococcal preparation, OK-432 augments the antitumor immunity of patients with gastric or colorectal cancer.
Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tobe T
Biotherapy; 1990; 2(3):213-22. PubMed ID: 2206774
[TBL] [Abstract][Full Text] [Related]
6. [Endoscopic preoperative intralesional injection of OK-432 in early gastric cancer].
Yamane T; Sagara Y; Suzuki G; Kasuga M; Sakita M; Fujita Y; Majima S
Gan To Kagaku Ryoho; 1984 Apr; 11(4):930-4. PubMed ID: 6721507
[TBL] [Abstract][Full Text] [Related]
7. [Augmentation of cytotoxicity of regional lymph node lymphocytes of gastric cancer after intratumoral injection of OK-432].
Kobayashi G
Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):68-76. PubMed ID: 2314383
[TBL] [Abstract][Full Text] [Related]
8. [Effect of intratumoral injection of the mixture of OK-432 and fibrinogen (OK/fbg) on gastric cancer].
Takeda T; Wakasugi T; Katsumoto Y; Sakita I; Nagaoka H; Morimoto H; Tsujinaka T; Monden T; Shiozaki H; Shimano T
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1458-60. PubMed ID: 1530293
[TBL] [Abstract][Full Text] [Related]
9. [Endoscopic administration of OK-432 in gastric cancer].
Inbe A; Sumii K; Haruma K; Uemura N; Tari A; Yoshihara M; Tokutomi T; Inaba Y; Sekito M; Ogoshi H
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):514-9. PubMed ID: 3954375
[TBL] [Abstract][Full Text] [Related]
10. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1607-15. PubMed ID: 2809385
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of immunological response of regional lymph node lymphocytes from patients with gastric cancer after endoscopic local injection of biological response modifier (BRM)].
Obi Y
Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):293-302. PubMed ID: 2051981
[TBL] [Abstract][Full Text] [Related]
12. Effects of 5'-DFUR and OK-432 on cytokines and thymidine phosphorylase in tumor tissue of gastric cancer patients.
Ohwada S; Ogawa T; Izumi M; Inoue T; Teshigawara O; Ikeya T; Kusaba T; Roppongi T; Iino Y; Morishita Y
Anticancer Res; 1997; 17(3C):2313-8. PubMed ID: 9216708
[TBL] [Abstract][Full Text] [Related]
13. [Adoptive immunotherapy against peritoneal metastases from stomach cancer--application of regional lymph node lymphocytes].
Okino T; Kan N; Mise K; Nakanishi M; Satoh K; Yamasaki S; Teramura Y; Inoue K; Ohgaki K; Tobe T
Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):613-20. PubMed ID: 2351854
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of pN-stage (TNM) in gastric cancer: an analysis of distribution of regional lymph nodes in node-positive patients.
Kikuchi S; Nemoto Y; Katada N; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Kakita A
Anticancer Res; 2002; 22(2B):1141-4. PubMed ID: 12168914
[TBL] [Abstract][Full Text] [Related]
15. Effect of intratumoral OK-432 administration of thymidine phosphorylase expression in human gastric carcinoma.
Ogawa K; Konno S; Takebayashi Y; Murayama M; Shimakawa T; Katsube T; Naritaka Y; Kajiwara T; Aiba M; Akiyama S
Anticancer Res; 2001; 21(2B):1257-62. PubMed ID: 11396196
[TBL] [Abstract][Full Text] [Related]
16. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):997-1012. PubMed ID: 2202770
[TBL] [Abstract][Full Text] [Related]
17. [Metastasis rates of lymph nodes and distribution in advanced gastric cancer and its clinical significance].
Nzengue JC; Zhan WH; Wang JP; Dong WG; Lan P; He YL; Chen ZX; Cai SR
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):506-9. PubMed ID: 17143796
[TBL] [Abstract][Full Text] [Related]
18. [Influence of intratumor administration of OK-432 on the tumor selectivity of 5'-DFUR].
Ogawa K; Katsube T; Konno S; Miura K; Wakasugi S; Watanabe T; Shimakawa T; Ishikawa S; Naritaka Y; Yagawa H
Gan To Kagaku Ryoho; 1995 Dec; 22(14):2095-100. PubMed ID: 8607621
[TBL] [Abstract][Full Text] [Related]
19. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):799-811. PubMed ID: 2196311
[TBL] [Abstract][Full Text] [Related]
20. Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.
Yamaguchi Y; Satoh Y; Miyahara E; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T
Anticancer Res; 1995; 15(5B):2201-6. PubMed ID: 8572625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
